Clinical course and prognostic factors of patients with SARS-COV-2: a
retrospective cohort study
Abstract
Objective: To explore the prognostic factors of different
prognosis SARS-COV-2 patients, including early cure (less than 3 weeks),
severe death, severe survival (duration of disease over 30 days, stable
condition). Methods: The general situation and laboratory tests and
other relevant indicators of 50 early cured patients, 50 severe
survivors and 50 severe deaths were studied. Results: Through a
retrospective cohort study, there were significant differences in age,
gender, respiratory distress symptoms, oxygen saturation of fingertip,
state of consciousness between cured mild patients and dead patients.
Diabetes and cerebrovascular disease were the main influencing factors
of previous medical history. Most of the laboratory test indicators,
such as the positive rate of nucleic acid test, blood routine test,
myocardial infarction marker, DIC, liver and kidney function,
inflammatory cytokines, are different between cured patients and dead
patients. Further compared the cases of severe survival and dead
patents, there were significant differences in gender,
breath shortness symptoms, oxygen saturation of fingertip,
consciousness, cerebrovascular disease. The laboratory tests showed that
the blood routine test, MH, CK-MB, pro BNP,BUN, Cr, albumin, DIC,
inflammatory factors and electrolyte disorders were great significance
to the prognosis. Further study showed that CTnI, Cr and DIC and
shortness of breath were independent prognostic factors of death.
Conclusion: Our data may suggest that the main influencing factor of
death was the degree of respiratory symptoms. The difference of
prognosis was more related to whether there were multiple organ
diseases, especially the heart, kidney and immune system dysfunction.